|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 19/11 | Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH | CI |
| 06/05/24 | Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Market Cap | 519K 450K 419K 385K 727K 49.5M 737K 4.93M 1.93M 24.66M 1.95M 1.91M 81.65M | P/E 2022 |
-0.11x | P/E 2023 | -0.31x |
|---|---|---|---|---|---|
| Enterprise Value | 22.05M 19.1M 17.79M 16.34M 30.89M 2.1B 31.31M 209M 82.18M 1.05B 82.8M 80.98M 3.47B | EV / Sales 2022 |
11.6x | EV / Sales 2023 | 10.1x |
| Free-Float |
-
| Yield 2022 * |
-
| Yield 2023 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.53% | -3.95% | +50.70% | +153.56% | 1,024B | |
| +0.21% | -2.68% | +53.20% | +51.79% | 618B | |
| -2.51% | -3.25% | +28.54% | +68.94% | 443B | |
| +0.06% | -0.42% | +37.53% | +30.67% | 349B | |
| -0.69% | -0.30% | +13.76% | +12.83% | 264B | |
| -7.37% | -4.40% | -0.74% | -44.28% | 209B | |
| -0.64% | +2.43% | +29.74% | +65.93% | 208B | |
| -0.82% | +0.70% | +15.05% | +72.05% | 162B | |
| +0.40% | +1.92% | +6.47% | -29.77% | 143B | |
| Average | -1.32% | -1.21% | +26.03% | +42.41% | 379.88B | |
| Weighted average by Cap. | -1.00% | -2.02% | +36.14% | +71.90% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.63M 1.41M 1.31M 1.21M 2.28M 155M 2.31M 15.46M 6.06M 77.32M 6.11M 5.98M 256M | 2.38M 2.07M 1.92M 1.77M 3.34M 227M 3.39M 22.66M 8.89M 113M 8.96M 8.76M 375M |
| Net income | -9.14M -7.92M -7.38M -6.78M -12.81M -872M -12.98M -86.87M -34.08M -434M -34.33M -33.58M -1.44B | -8.02M -6.94M -6.47M -5.94M -11.23M -764M -11.38M -76.16M -29.87M -381M -30.1M -29.44M -1.26B |
| Net Debt | 17.85M 15.47M 14.41M 13.23M 25.02M 1.7B 25.35M 170M 66.54M 848M 67.04M 65.57M 2.81B | 21.53M 18.65M 17.37M 15.96M 30.17M 2.05B 30.57M 205M 80.24M 1.02B 80.85M 79.07M 3.39B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
